Rani Therapeutics Holdings Balance Sheet Health
Financial Health criteria checks 3/6
Rani Therapeutics Holdings has a total shareholder equity of $5.8M and total debt of $28.3M, which brings its debt-to-equity ratio to 490.1%. Its total assets and total liabilities are $43.5M and $37.8M respectively.
Key information
490.1%
Debt to equity ratio
US$28.31m
Debt
| Interest coverage ratio | n/a |
| Cash | US$30.40m |
| Equity | US$5.78m |
| Total liabilities | US$37.77m |
| Total assets | US$43.54m |
Recent financial health updates
Does Rani Therapeutics Holdings (NASDAQ:RANI) Have A Healthy Balance Sheet?
Jul 16
Is Rani Therapeutics Holdings (NASDAQ:RANI) Weighed On By Its Debt Load?
Mar 20We're Not Very Worried About Rani Therapeutics Holdings' (NASDAQ:RANI) Cash Burn Rate
Feb 13Recent updates
Does Rani Therapeutics Holdings (NASDAQ:RANI) Have A Healthy Balance Sheet?
Jul 16Is Rani Therapeutics Holdings (NASDAQ:RANI) Weighed On By Its Debt Load?
Mar 20Rani Therapeutics enters $45M loan agreement to support advancement and pipeline development
Aug 08We're Not Very Worried About Rani Therapeutics Holdings' (NASDAQ:RANI) Cash Burn Rate
Feb 13Financial Position Analysis
Short Term Liabilities: RANI's short term assets ($32.4M) exceed its short term liabilities ($20.2M).
Long Term Liabilities: RANI's short term assets ($32.4M) exceed its long term liabilities ($17.6M).
Debt to Equity History and Analysis
Debt Level: RANI has more cash than its total debt.
Reducing Debt: Insufficient data to determine if RANI's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: RANI has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: RANI has less than a year of cash runway if free cash flow continues to reduce at historical rates of 20.9% each year